Navigation Links
begins in Biological Technology

America's Organic Home-Fueling Movement Begins in Los Angeles

Green Celebrities Attend World's First E-Fuel MicroFuelerTM Installation Los Angeles, CA (PRWEB) August 1, 2009 -- The future of filling up your tank at home has arrived! The first of the revolutionary portable home micro-refinery systems that turns organic waste into a...

FluMist(R) Begins Shipping for 2009-2010 Influenza Season

GAITHERSBURG, Md., July 28 /PRNewswire/ -- MedImmune announced today that it has begun shipping its seasonal influenza vaccine FluMist((R) )(Influenza Vaccine Live, Intranasal) to vaccine distributors who service health care providers throughout the United States. MedImmune ex...

Mach One Corporation Begins Trading on the OTC Bulletin Board Under the Symbol 'MNCN'

BELGIUM, Wis., July 8 /PRNewswire-FirstCall/ -- Mach One Corporation (OTC Bulletin Board: MNCN), an innovative, global wellness solutions company, today announced that, effective immediately, its stock is trading on the OTC Bulletin Board under the symbol "MNCN." The Company's stock had previously...

Sinovac Begins the Production of Influenza A (H1N1) Vaccine

BEIJING, June 8 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA ), a leading developer and provider of vaccines in China, announced today that it begins the production of a vaccine against influenza A (H1N1) virus. The virus seed was received from US CDC and was delivered to the co...

Johnson & Johnson Begins Tender Offer to Acquire Cougar Biotechnology

NEW BRUNSWICK, N.J., June 5 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ ), through a new wholly-owned subsidiary, Kite Merger Sub, Inc., today will commence a cash tender offer to purchase all outstanding shares of common stock of Cougar Biotechnology, Inc. (Nasdaq: CGRB ). Joh...

DHS Begins Test of Biometric Exit Procedures at Two U.S. Airports

Next step toward deploying biometric exit procedures for international travelers WASHINGTON, May 28 /PRNewswire/ -- The U.S. Department of Homeland Security (DHS) today began collecting biometrics - digital fingerprints and photographs - from non-U.S. citizens departing the United States as p...

Vaxart Begins Animal Testing of H1N1 Flu Vaccine Candidate

SAN FRANCISCO, May 26 /PRNewswire/ -- Vaxart, Inc., a biotechnology company focused on the development of oral vaccines, announced today that the company has created a candidate vaccine for H1N1 influenza (swine flu). On Saturday, May 23, Vaxart began testing for immune responses in animals, just ...

Advanced Life Sciences Common Stock Begins Trading on OTC Bulletin Board

- Company to Host 2009 First Quarter Financial Results Conference Call and Webcast - CHICAGO, May 6 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. announced today that its common stock is eligible for quotation and trading on the Over-the-Counter Bulletin Board (OTCBB) under ...

Shire begins the year with a strong performance

PHILADELPHIA and DUBLIN, April 30 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY ) the global specialty biopharmaceutical company, announces results for the three months to March 31, 2009. Financial Highlights ...

Inimex Pharmaceuticals begins First Clinical Study of an Innate Defense Regulator

Phase 1 healthy volunteer study of IMX942 will provide human safety and pharmacodynamic data VANCOUVER, April 28 /PRNewswire/ - Inimex Pharmaceuticals is pleased to announce that its novel Innate Defense Regulator (IDR) IMX942 was administered to human subjects for the first time on...

NanoLogix Begins Construction of Production Facility for Medical Test Kits

HUBBARD, Ohio, April 21 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (OTC: NNLX) -- NanoLogix Inc. has begun construction on a 2,800 square foot manufacturing facility at its headquarters in Hubbard, Ohio. It will contain a production cleanroom, cold-storage vault, and shipping and receiving area to...

Groundbreaking Research Begins for Pancreatic and Lung Cancers

Georgia Institute of Technology and Saint Joseph's Hospital Team Up ATLANTA, April 1 /PRNewswire/ -- Georgia Tech and Saint Joseph's Hospital have joined together to begin the first regional research program to study the genetics and cell biology of pancreatic cancer. Tissue and serum sa...

Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary Immunodeficiency Patients

DEERFIELD, Ill. and SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- Baxter International Inc. and Halozyme Therapeutics, Inc. (Nasdaq: HALO ) today announced the start of a Phase III clinical trial of Baxter's GAMMAGARD LIQUID [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the E...

Irvine Dermatologist Begins In-office Clinical Studies -- Nissan Pilest, MD Combines Multi-Use Botox in Laser Resurfacing Clinical Studies

Training Physician for both Botox and Fraxel Repair, Nissan Pilest Board Certified Dermatologist in Orange County begins in-office clinical procedure studies to track the effectiveness of using Botox as a pre-treatment to enhance the improvements of fractional CO2 skin resurfacing. Specific to th...

Alimera Sciences Begins Pilot Study to Assess Safety and Efficacy of Iluvien(TM) in Patients With Bilateral Geographic Atrophy Due to AMD

ATLANTA, Dec. 11 /PRNewswire/ -- Alimera Sciences Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported that enrollment has begun for a pilot study to assess the safety and eff...

SemBioSys begins phase I/II trial of insulin produced in plant seeds

TSX symbol: SBS CALGARY, Dec. 3 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing protein pharmaceuticals in crop plants, today announced that it has initiated a phase I/II clinical trial of its plant-produced insulin with the first injection o...

Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients

SAN DIEGO, Nov. 3 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO ), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced it has started a Phase 2 study of proprietary recombinant human hyaluronidase enzyme...

TorreyPines Therapeutics Begins Dosing in a Phase I Multiple Dose Clinical Trial of NGX426, Oral Prodrug of Tezampanel

LA JOLLA, Calif., Oct. 20 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX ) today announced it initiated dosing of the first cohort of subjects in a Phase I multiple dose clinical trial of NGX426, the oral prodrug of its most advanced product candidate, tezampanel. The trial is d...

Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline

U.S. National Institutes of Health, The Infectious Disease Research Institute and Eli Lilly and Company Announce Launch and Board of Advisors SEATTLE, Oct. 7 /PRNewswire-FirstCall/ -- The Lilly TB Drug Discovery Initiative today announced its first acquisition of compounds for further devel...

The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline

U.S. National Institutes of Health, The Infectious Disease Research Institute and Eli Lilly and Company Announce Launch and Board of Advisors SEATTLE, Oct. 7 /PRNewswire-FirstCall/ -- The Lilly TB Drug Discovery Initiative today announced its first acquisition of compounds for further devel...

South Africa Begins Introduction of PREVENAR into Childhood Immunization Program

- First African Nation Plans to Phase in Routine Vaccination Program Against Pneumococcal Disease for Infants and Young Children - COLLEGEVILLE, Pa., Sept. 15 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), today announced that South Africa has initiat...

Cellectar, Inc. Begins GMP Production

Radiopharmaceutical production facility to support clinical development for lead drug candidate and other molecules MADISON, Wis., Aug. 18 /PRNewswire/ -- Cellectar, Inc., a privately-held radiopharmaceutical company that designs, develops and manufactures products to detect, trea...

GSK Begins Shipments of Fluarix(R) and FluLaval(R) to U.S. Customers for 2008-2009 Influenza Season

GSK anticipates delivery of at least half of shipments by the end of August PHILADELPHIA, Aug. 11 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today announced that it will begin shipment of FLULAVAL(R) [Influenza Virus Vaccine] and FLUARIX(R) [Influenza Virus Vaccine] to U.S. customers ...

China Biologic Products Begins Annual Maintenance of its Production Facilities

TAIAN CITY, Shandong, China, Aug. 1 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that the Company began it...

Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company

LA JOLLA, Calif., July 21 /PRNewswire/ -- Zenobia Therapeutics, Inc. (Zenobia) announced today that they have initiated research at their facility in La Jolla, California. Zenobia was founded June 1, 2008, is privately funded and moved into their new laboratory and office facilities on July 1....

Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting Stent

XIENCE V USA Study to Evaluate Treatment of Coronary Artery Disease Patients in Real-World Setting ABBOTT PARK, Ill., July 9 /PRNewswire-FirstCall/ -- Abbott today announced the start of the XIENCE V(TM) USA post-approval study, with six hospital centers already recruitin...

China Biologic Products Begins Operation of its Newly Constructed Plasma Collection Station in Qi He County, Shandong Province

TAIAN CITY, Shandong, China, July 9 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that the Company has comm...

Medimetriks Pharmaceuticals, Inc. Begins Operations

Bradley Pharmaceuticals Founder and Senior Management Form Company Specializing in Dermatology and Podiatry Markets FAIRFIELD, N.J., May 13 /PRNewswire/ -- Medimetriks Pharmaceuticals, Inc. announced today that it commenced operations. The newly-formed Company, led by the founder...

CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Company's Common Stock and Trading in Post-split Shares Begins May 9, 2008

Split Intended to Maintain Nasdaq Listing and Attract Additional Investors as Company Enters Next Growth Phase SAN DIEGO, May 8 /PRNewswire-FirstCall/ -- CardioDynamics (Nasdaq: CDIC), the innovator and leader of BioZ(R) impedance cardiography (ICG) technology, today announced ...

Nikon Instruments Begins Direct Sales and Technical Support in Southern California and Rocky Mountain Territories

MELVILLE, N.Y., May 7 /PRNewswire/ -- Nikon Instruments, Inc. (http://www.nikoninstruments.com ) is pleased to announce that it has begun direct sales and technical support for Nikon's BioScience Microscopes, Confocal Systems and Digital Imaging products, along with Industrial products includ...

Thomson Scientific Begins Expansion of Web of Science

162 New Journals Enrich Current Coverage With Regional Perspective PHILADELPHIA and LONDON, April 1, 2008 /PRNewswire/ -- Thomson Scientific, a leading provider of information solutions to the worldwide research and business communities, today announced that 162 regional social science jour...

Ohio Task Force Begins Mission of Creating a New 21st Century Industry

Appointed members aim to build business through conversion of agricultural products into advanced materials COLUMBUS, Ohio, March 27 /PRNewswire/ -- The state of Ohio has appointed thirteen members, representing a wide range of expertise in the fields of chemicals, polymers a...

Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia

QUEBEC CITY, March 26 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported dosing has commenced with its flagship product candidate, cetrorelix, the Company's lead luteinizing hor...

SPO Medical Begins Shipping PulseOx 6000(TM) and PulseOx 6100(TM)

New Products for Medical Professionals, Hospital and Managed Care Facilities NEW YORK, February 26 /PRNewswire-FirstCall/ -- SPO Medical Inc. (SPOM)( http://finance.yahoo.com/q?s=SPOM.OB ), a leading developer of biosensor and microprocessor technologies for u...

Care to Care Begins Providing Radiology Benefit Management Services to Touchstone Health

NEW YORK, Feb. 25 /PRNewswire/ -- Care to Care, a specialty Radiology Benefit Management (RBM) company, announced today that it has signed Touchstone Health HMO Inc. as a client. As a result of this new partnership, Care to Care's client portfolio has grown to over 700,000 lives. (Logo: htt...

Phlo Affiliate Begins Roll Out to Metropolitan New York City Account Base

JACKSONVILLE, Fla., Dec. 27 /PRNewswire-FirstCall/ -- Phlo Corporation (Pink Sheets: PHLC) ("Phlo") announced today that one of its affiliates (the "Company") has completed the initial shipment of its vitality beverage product, AQISS(TM), as part of a roll out of the product in the metropolita...

Medical Services Begins Working With United States Companies for Distribution of Its Products

EDMONTON, Alberta, Nov. 6 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pink Sheets: MSITF) is pleased to announce that it has begun working with U.S. based Companies to expand its distribution network worldwide. These companies have established distribution networks and are i...

Genzyme Begins Major Expansion of Boston Manufacturing Facility

Project to Support the Increasing Global Need for Genzyme Products CAMBRIDGE, Mass., Sept. 18 /PRNewswire-FirstCall/ -- Genzyme Corp. (Nasdaq: GENZ ) today broke ground on a significant expansion of its flagship manufacturing facility at Allston Landing in Boston. The $150 million project ...

DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board

SOMERSET, N.J., Aug. 28 /PRNewswire-FirstCall/ -- DOV Pharmaceutical, Inc. ("DOV" or the "Company") (OTC Bulletin Board and Pink Sheets: DOVP) announced today that its common stock is now being quoted on the OTC Bulletin Board. The Company understands that its common stock is also still being ...

Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins

- 85,000 Expected to Enroll in Phase 4 Study Initiated Pre-Registration - COLLEGEVILLE, Pa., Sept. 23 /PRNewswire/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), today announced the initiation of the Community Acquired Pneumonia Immunization Trial in Adults a major study in adul...
Other Tags
(Date:4/17/2014)... Professor Luca Razzari of the nergie Matriaux Tlcommunications ... from the John R. Evans Leaders Fund of ... acquisition of state-of-the-art biotech and nanophotonics equipment. To ... the Ministre de l,Enseignement suprieur, de la Recherche, ... These new laboratories will help us develop new ...
(Date:4/17/2014)... Stem cells in bone marrow need to produce hydrogen ... tissue, according to a new study from the Center ... of Dentistry of USC. , Professor Songtao Shi, principal ... sulfide produced by the cells governs the flow of ... cellular signals that results in osteogenesis, or the creation ...
(Date:4/17/2014)... Ongoing deforestation and fragmentation of forests in the ... remnant forests, contributing to rapid and widespread forest ... of researchers., The findings show that forests in ... severe droughts coupled with forest fires lead to ... said Jennifer Balch, assistant professor of geography, Penn ...
Breaking Biology News(10 mins):New state-of-the-art biotech and nanotech equipment for INRS 2Drought and fire in the Amazon lead to sharp increases in forest tree mortality 2Drought and fire in the Amazon lead to sharp increases in forest tree mortality 3
(Date:4/18/2014)... University psychologists have made a brain-related discovery that ... disorders. , This discovery opens up the possibility ... suppress a specific brain activity that the researchers ... The Journal of Neuroscience has just ... McDonald, an associate professor of psychology and his ...
(Date:4/17/2014)... show signs of chronic inflammation in non-cancerous prostate tissue ... prostate cancer than those with no inflammation, according to ... the Johns Hopkins Kimmel Cancer Center. , The link ... men with so-called high-grade prostate cancer those with ... the presence of the most aggressive and rapidly growing ...
(Date:4/17/2014)... Biology and Medicine a multidisciplinary research team ... in the Institute of Genomic Biology (IGB) on ... describe their recent work on subcellular redox homeostasis. ... functions including energy metabolism, signaling, and transcriptional processes. ... cellular behavior, redox status has been recognized as ...
(Date:4/17/2014)... created a new technology for modifying human cells ... body and selectively target cancer and other sites ... monitor and modify human physiology is a promising ... technology enabled bioengineers to build such devices that ... a customized fashion. , "The project addressed a ...
(Date:4/17/2014)... one in five infants in the United States annually ... several months after birth. Research into probiotic use for ... April 1, 2014 issue of the British Medical ... "Probiotics and Infant Colic," concluding that the use of ... did not reduce crying or fussing in infants ...
Breaking Medicine News(10 mins):Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Building 'smart' cell-based therapies 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
Other Contents